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influence the genotype–phenotype re-
lationship (Covello et al., 1998; Leach-
man et al., 2005). No patients have
been reported with K6b mutations and
pure steatocystoma multiplex (McLean
et al., 2005), but our patient does have
multiple flesh-colored papules which
extrude greasy contents, consistent with
steatocystomas.
Treatment for pachyonychia conge-
nita is limited and fairly unsuccessful by
current standards. The most debilitating
feature as reported by patients is plantar
pain, with the most promising treat-
ments thus far consisting of activities to
reduce friction and botulinum toxin to
decrease sweating (Leachman et al.,
2005; Milstone et al., 2005). Other
features, such as hyperkeratosis of the
nails, cysts, and mucous membrane
lesions are managed by symptomatic
treatment ranging from use of humec-
tants and mechanical removal of kera-
tin in thick nails to excision or incision
and drainage of cysts. Fortunately,
newer and better gene-based treatments
are on the horizon. Exciting options
being considered include triplex-form-
ing oligonucleotides or zinc-finger
nucleases to inactivate or induce
correction of the mutant allele and
most promising to date, the use of
targeted small inhibitory RNAs to si-
lence gene expression of the mutant
allele (Lewin et al., 2005; Hickerson
et al., 2006). Hopefully, with continued
research into the genetics of pachyo-
nychia congenita, the goal of gene-
based therapy will become attainable.
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TO THE EDITOR
In hyperkeratosis and acanthosis, periph-
eral branches of sensory nerves increase
remarkably in number, particularly in the
epidermis of inflamed skin (Mihm et al.,
1976; Pincelli et al., 1990; Tobin et al.,
1992; Ostlere et al., 1995). It has been
supposed that nerve growth factor (NGF)
secreted from keratinocytes in inflamed
skin may induce the sprouting of the
neurites of sensory fibers (Dou et al.,
2006) because of an increase in both
NGF expression in the keratinocytes
(Kinkelin et al., 2000; Takano et al.,
2005; Tanaka and Matsuda, 2005) and
cutaneous innervation in the epidermis
in the inflamed skin (Horiuchi et al.,
2005). The NGF effect may occur
via low-affinity receptors (p75) and
high-affinity receptors (TrkA), although
direct evidence for this is lacking.
This study clearly demonstrates, by
using p75 knockout mice, that sprout-
ing of sensory fibers in the epidermis
and hyperkeratosis and acanthosis of
the inflamed skin are induced by an
NGF–p75 pathway.Abbreviations: NGF, nerve growth factor; PC, picryl chloride (2,4,6-trinitrochlorobenzene)
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Five female mice with a C57BL/6j
background and p75 gene mutation
(Lee et al., 1992) (Jackson Laboratory,
Maine) were used in this study. The
anterior abdominal skin was painted
with 100ml of a 5% picryl chloride (PC)
solution (Tokyo Kasei Kogyo, Tokyo,
Japan) for the initial sensitization. The
cutaneous reaction in the sensitized
C57BL/6j and p75 knockout mice was
evoked by repeated paintings of both
ears with 15 ml of 1% PC solution.
Controls received repeated paintings
of the ears with 15 ml of solvent without
the PC. The PC challenge was repeated
once a week for 4 weeks, followed
by three times per week, 10 times in
total, from 7 days after the initial
sensitization. Histochemistry for sub-
stance P, protein gene product 9.5,
NGF, and p75 was then performed.
The specificity of the immunoreaction
for substance P and NGF was confirmed
by the absorption test. Specificity for p75
immunoreaction was checked in p75
knockout mice (Figures 1g, h and 2h, i).
As a preliminary experiment, PC treat-
ment was found to cause inflammation
of the skin of two male NC/Nga Tnd
Cr1j mice. All animal experiments were
carried out in accordance with a proto-
col approved by the institutional Animal
Care and Use Committee of Osaka
University.
PC treatment on the C57BL/6 mouse
skin resulted in a remarkable hyper-
keratosis and acanthosis (Figure 1).
Figure 1a–d shows the changes of the
localization of substance P fibers
and protein gene product 9.5 fibers in
the epidermis of C57BL/6 mice after
PC treatment, which caused sprouting
of sensory fibers in the epidermis of
the inflamed skin (Figure 1b and d).
Figure 1e–h shows the alteration of
NGF and p75-like immunoreactivity in
the PC treatment C57BL/6 mice. NGF
was weakly expressed in the keratino-
cytes of C57BL/6 mice without the PC
treatment (Figure 1e). In the PC-treat-
ment mice, immunoreactivity in the
keratinocytes increased in number in
the epidermis (Figure 1f). No NGF-
positive fibers were seen in the
normal or inflamed skin. The alteration
of p75 expression in the keratinocytes
was similar to that found with NGF
(Figure 1g and h). The most remarkable
change found in the expression of
p75 in the inflamed skin was the
presence of a number of p75-positive
fibers in the epidermis (Figure 1h),
where no p75-labeled fibers were seen
in the normal epidermis (Figure 1g
inset).
In contrast to C57BL/6 mice, in the
p75 knockout mice, hyperkeratosis and
acanthosis were inhibited remarkably
after PC treatment (Figure 2a–c). In
addition, no sprouting of substance P
fibers was identified in the epidermis in
p75 knockout mice, both with and
without PC treatment (Figure 2d and e).
PC treatment of p75 knockout mice
failed to increase the number of NGF-
expressing keratinocytes compared with
the PC-treated wild-type mice (Figure 2f
and g). In the epidermis of p75 knock-
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Figure 1. The histological analysis of the epidermis in C57BL/6 mice following PC treatment. (a and b) Changes
in the immunoreactivity for substance P, (c and d) protein gene product 9.5, (e and f) NGF, and (g and h) p75
in the epidermis (auricle) of C57BL/6 mice (a, c, e, and g) without PC treatment and (b, d, f, and h) with
PC treatment are shown. (a–d) The sprouting of sensory nerve fibers containing substance P and protein gene
product 9.5 in the epidermis (auricle). In the control mice, as shown in inset of (a and c), a few substance P and
protein gene product 9.5 fibers were seen in the epidermis. (b and d) In the PC-treated mice, substance P and
protein gene product 9.5-positive fibers (arrows) were seen in the epidermis. (e and g) In the control mice,
keratinocytes were weakly immunoreactive for NGF and p75 in the epidermis. (f and h) In the PC-treated mice,
hyperkeratosis and acantosis were identified and strong immunoreactivity for NGF and p75 was observed
in the epidermis. Only a few P75-immunostained cells were seen in the basal layer of the epidermis (inset of g).
As for the p75 expression, in the control mice, few P75 fibers were seen in epidermis, whereas many P75-positive
nerve fibers (arrows) were seen in the epidermis of the (h) PC-treated mice. Bar¼ 50mm.
www.jidonline.org 2063
M Taniguchi et al.
Role of P75 in the Induction of the Sprouting of Sensory Nerve Fibers
out mice with and without PC treat-
ment, p75 expression was not seen in
the skin, including the keratinocytes and
sensory fibers (Figure 2h and i).
Inflammation causes hyperkeratosis,
acanthosis, and sprouting of sensory
nerve fibers. This study revealed the
upregulation of NGF and p75 in the
keratinocytes and the existence of p75-
positive sprouting nerve fibers in the
epidermis of the inflamed skin. These
findings strongly suggest that hyperker-
atosis, acanthosis, and sprouting of the
sensory fibers in the epidermis are
attributable to the NGF-p75 pathway.
In fact, we demonstrated that in the
p75 knockout mice, even under the PC
treatment, sprouting of sensory fibers
could not be identified and hyperker-
atosis and acanthosis were inhibited
remarkably. These findings indicate
that hyperkeratosis, acanthosis, and
sprouting of the sensory fibers in the
epidermis in the inflamed skin are
induced mainly by the NGF-p75 path-
way in the epidermis.
In inflamed skin, both NGF and TrkA
are expressed in the increased kerati-
nocytes (Dou et al., 2006). In addition,
a significant increase of keratinocytes
was seen in the p75 knockout mice
(Figure 2a and b). Accordingly, it is
possible that the NGF-TrkA pathway is
partly involved in hyperkeratosis
and acanthosis in the inflamed skin
(Raychaudhuri et al., 2004). In any
case, TrkA knockout mice may help to
resolve this problem.
The findings concerning the expres-
sion of p75 in epidermis, not only in
normal skin but also in skin with
cutaneous inflammation, are controver-
sial. Previous studies reported that basal
keratinocytes are immunoreactive for
p75 in normal human skin, decreasing
the expression under inflammation (Jo-
hansson et al., 2002; Dou et al., 2006).
However, this study showed that the
p75 expression in keratinocytes in-
creased after PC treatment (Figure 1g
and h). On the other hand, as to sensory
fibers, Dou et al. (2006) and Johansson
et al. (2002) found an increase of p75
fibers in the dermis but failed to
demonstrate them in the epidermis,
although other authors confirmed the
presence of sprouting sensory fibers in
the epidermis (Ostlere et al., 1995;
Chan et al., 1997). In contrast,
Bull et al. (1998) described a
decrease of p75 fibers in the inflamed
dermis. We have detected the sprouting
of p75 fibers in the epidermis together
with an increase in the number of
p75 fibers in the dermis during inflam-
mation. The discrepancy among
these studies might be attributed to
the different species or fixation methods
used.
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Figure 2. The histological analysis of the epidermis in p75 knockout mice following PC treatment.
(a and b) The histological change of the epidermis (auricle) of p75 knockout mice (a) without PC
treatment and (b) with PC treatment, stained by hematoxylin. (c) A marked hyperkeratosis and acanthosis
was identified in the epidermis of C57BL/6 mice with the PC treatment. (b) However, in the p75 knockout
mice with PC treatment, hyperkeratosis and acanthosis was remarkably inhibited. Bar¼50 mm. Changes
in the immunoreactivity for (d and e) substance P, (f and g) NGF, and (h and i) p75 in the epidermis
(auricle) of the p75 knockout mice (d, f, and h) without PC treatment and (e, g, and i) with PC treatment
are shown. (d and e) No substance P fibers were found in either the epidermis or dermis of either
PC-treated or non-treated mice. In the epidermis of p75 knockout mice, immunoreactivity for NGF was
seen in the keratinocytes of the epidermis (f) without PC treatment and (g) with PC treatment. Expression
of NGF in the epidermis was stronger in the PC-treated mice than in non-PC-treated mice. Similarly,
in the p75 knockout mice, no immunoreactivity for p75 was seen in the keratinocytes or sensory
nerve fibers (h) without PC treatment or (i) with PC treatment. Bar¼ 20mm.
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